Emory University

BrainCheck Plan Wins "Care Management Innovation Award" in 8th Annual MedTech Breakthrough Awards

Retrieved on: 
木曜日, 5月 9, 2024
Model, Medtech, FDA, DNP, FAAN, Dementia, Risk, Professor, Health, DSM-IV codes, MD, Doctor of Philosophy, Alzheimer's disease, Disease, Patient, RN, Caregiver, Assessment, Emory University, Quality of life, Deficit spending, Nursing

AUSTIN, Texas , May 9, 2024 /PRNewswire/ -- BrainCheck, Inc., a digital health innovator delivering next-generation technology into the growing digital cognitive assessment market, today announced that its care planning solution, BrainCheck Plan™, was selected as the winner of the "Care Management Innovation Award" in the 8th annual MedTech Breakthrough Awards program, which recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries. This year's program attracted thousands of nominations from more than 18 countries worldwide.

Key Points: 
  • "Following information provided by BrainCheck Screen™ and Assess™, our comprehensive care planning is the critical next step for providers, patients and caregivers," said Kim Rodriguez, CEO of BrainCheck.
  • "The evolution of the BrainCheck platform reflects our customers' evolving needs, and this recognition of our product further validates the value of our technology."
  • "With BrainCheck Plan, we can quickly customize care plans and document recommendations for patients and caregivers, based on individual needs.
  • BrainCheck Plan is equipping providers with an innovative solution to support the journey for patients and their families."

Ibotta Appoints Stephen Bailey to Board of Directors and Shalin Patel as new Head of Investor Relations

Retrieved on: 
火曜日, 5月 7, 2024
Yale Law School, School, University, The Carlyle Group, Software, Applied science, IPO, Bailey, Emory University, Information services, Match Group, Management

DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA), a leading technology company providing digital promotions and performance marketing solutions, announced today two recent appointments: as previously disclosed, Stephen Bailey, CEO and co-founder of ExecOnline, joined Ibotta’s Board of Directors when Ibotta completed its IPO, and Shalin Patel has joined to lead Investor Relations.

Key Points: 
  • DENVER, May 07, 2024 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA), a leading technology company providing digital promotions and performance marketing solutions, announced today two recent appointments: as previously disclosed, Stephen Bailey, CEO and co-founder of ExecOnline, joined Ibotta’s Board of Directors when Ibotta completed its IPO, and Shalin Patel has joined to lead Investor Relations.
  • “Stephen brings public company board experience, having served on the Match Group board, along with deep expertise in leadership from his tenure at ExecOnline.
  • Prior to that, he served as CEO and Chief Product Officer of Frontier Strategy Group,a software and information services business.
  • Prior to joining Ibotta, Patel was Technology Sector Head at Artisan Partners' Antero Peak Group.

Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery

Retrieved on: 
水曜日, 5月 8, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, FDA, Drug design, Hearing, Kaiser, Risk, Ligand, Fasudil, Machine learning, Liotta, Partnership, Virology, ROCK, DRS, Engineering, Mathematics, Algorithm, Therapy, Microsoft, Chemistry, Neurology, DSM-IV codes, Medicine, Failure, Biology, Drug development, Emory University, Drug discovery, Chronic kidney disease, Microsoft Research, Cheminformatics, Pharmaceutical industry

Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery.

Key Points: 
  • Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery.
  • “Avicenna is applying novel ML methods to navigate the unknowns in medicinal chemistry and design around them.
  • Our methods allow a drug design team to learn from years of failure and optimize against validated targets more efficiently.
  • For more information on Avicenna and its technology platform or to inquire about partnership opportunities, visit www.avicenna-bio.com .

DR. KIYA MOVASSAGHI ASSUMES PRESIDENCY OF THE AESTHETIC SOCIETY, CHARTING A COURSE FOR GLOBAL PARTNERSHIPS AND ADVANCING AESTHETIC EDUCATION

Retrieved on: 
日曜日, 5月 5, 2024
Education, General surgery, Breast, Resident, Weight loss, Partnership, NYU, University, Face, Rhinoplasty, Woman, DMD, Large, Abdominoplasty, Navy, Executive Committee, Memorandum, Mount Sinai Hospital, Harvard Medical School, Fifth Avenue, Emory University, Royal college, Microsoft, Safety, Publication, Plastic surgery, Division, The Hamptons, School, Society, Patient, Medical school, University Health Network, Elective surgery, FACS, Annual general meeting, Massachusetts General Hospital, Women's College Hospital, Dentistry

VANCOUVER, BC, May 5, 2024 /PRNewswire/ -- The Aesthetic Society proudly announces the appointment of Dr. Kiya Movassaghi, a board-certified plastic surgeon from Eugene, OR, as the President of The Aesthetic Society. Dr. Movassaghi's leadership will focus on strategically fortifying The Society's position as the global leader in education and innovation in the aesthetic marketplace.

Key Points: 
  • Dr. Movassaghi's leadership will focus on strategically fortifying The Society's position as the global leader in education and innovation in the aesthetic marketplace.
  • "I am honored to assume the presidency of The Aesthetic Society," said Dr. Movassaghi.
  • Global outreach through Memorandums of Understanding (MOUs) will be instrumental in shaping our engagement and alliances among our international colleagues.
  • A 1995 graduate of Harvard Medical School, Dr. Movassaghi completed a three-year plastic surgery residency at the Harvard Combined Plastic Surgery Program.

WWPR WELCOMES RETURNING MEMBERS TO 2024 - 2025 ADVISORY COUNCIL

Retrieved on: 
金曜日, 5月 3, 2024
Wells Fargo, Virginia University, WWPR, Teaching, Life, Growth, Journalism, American University, Georgetown University, Leadership studies, POLITICO, Woman, Delhi University, Economics, Axios, Empowerment, The Washington Post, The New York Times, Elon University, Inside Philanthropy, Committee, WVU, Communication, Emory University, Corporate communication, Advisory Council, West Virginia University, Health communication, Woman of the Year, George Washington University, Minerva, Health, Female, Chicago Sun-Times, Psychology, Capital One, Marketing, Society, DARPA, Partnership, Sociology, Science, Introduction, Master, IPR, Capital city, Bloomberg, Turner, Nursing

WASHINGTON, May 3, 2024 /PRNewswire/ -- Washington Women in Public Relations (WWPR), a leading resource for female communications professionals in the nation's capital, today announces its 2024 - 2025 Advisory Council, a group that provides WWPR's leadership with strategic advice on the direction of the organization.

Key Points: 
  • WASHINGTON, May 3, 2024 /PRNewswire/ -- Washington Women in Public Relations (WWPR), a leading resource for female communications professionals in the nation's capital, today announces its 2024 - 2025 Advisory Council, a group that provides WWPR's leadership with strategic advice on the direction of the organization.
  • The Advisory Council is comprised of local female leaders in the communications and public relations industry.
  • This year, WWPR is pleased to welcome back the 2022 - 2023 Advisory Council members – Susan Matthews Apgood, Sukhi Sahni, Hillarie Turner and Danielle Veira – for another two-year term.
  • "We are thrilled to welcome back our esteemed Advisory Council members, a group of amazing industry veterans with a multitude of experience," said Chelsea Echavarria, WWPR President.

Walter M. Kimbrough to Deliver Opening Keynote at 2024 Annual Meeting for Minority Serving - Cyberinfrastructure Consortium

Retrieved on: 
木曜日, 5月 2, 2024
Education, University, UNCF, Master, Chancellor (education), Male, Mayflower, Domination, Human, Albany State University, Dillard University, Challenge, Miami University, Mayflower Hotel, Economic development, Alpha Phi Alpha, Emory University, Philander Smith College, Old Dominion University, Culture, Georgia State University

WASHINGTON, May 2, 2024 /PRNewswire/ -- Walter M. Kimbrough — the former president of Dillard University and a prominent figure in HBCU advocacy  — will deliver the opening keynote at the 2024 Annual Meeting for the Minority Serving - Cyberinfrastructure Consortium (MS-CC), May 29-31, in Washington, D.C.

Key Points: 
  • WASHINGTON, May 2, 2024 /PRNewswire/ -- Walter M. Kimbrough — the former president of Dillard University and a prominent figure in HBCU advocacy  — will deliver the opening keynote at the 2024 Annual Meeting for the Minority Serving - Cyberinfrastructure Consortium (MS-CC), May 29-31, in Washington, D.C.
  • Kimbrough began his career in student affairs, holding the position of vice president for student affairs at Albany State University.
  • Prior to this role, he held positions at Emory University, Georgia State University, and Old Dominion University.
  • Kimbrough leveraged his influence as president of a historically Black college and university (HBCU) to become a voice in the community.

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

Retrieved on: 
水曜日, 5月 1, 2024
Optical, Health, Surgery, Medical Devices, Corporation, Science, Medtech, Near-sightedness, Law, University, Presbyopia, American Tower, Believer, EVO, General counsel, OTC, Marketing, Commerce, Johnson & Johnson, STAAR, Surgeon, University School, Business, Partner (business rank), CareFusion, Contact, Duke University, NuVasive, Senior, Patient, Multimedia, Global marketing, Emory University, Associate, Astigmatism, Economics, Nate, Growth, Engineering, Management

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel.

Key Points: 
  • STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel.
  • View the full release here: https://www.businesswire.com/news/home/20240501408389/en/
    “We are thrilled to strengthen the STAAR team with the addition of Nancy and Nate, two seasoned executives with extensive senior leadership experience.
  • “Nancy is a perfect fit for the newly created Chief Marketing Officer position and will be critical to driving our brand awareness and innovation globally.
  • “I am thrilled to join the STAAR leadership team at a time of significant opportunity and growth for our vision correction lenses,” said Nate Sisitsky.

Johnson Downie and Lippman Jungers Welcome New Partners Josh Dull and Meredith Frank

Retrieved on: 
月曜日, 4月 29, 2024
Legal, Professional Services, Law, University, Southeastern United States, Pleasure, Downie, Emory University

Johnson Downie and Lippman Jungers, the world’s leading legal search firm, today announced the addition of Josh Dull and Meredith Frank as partners.

Key Points: 
  • Johnson Downie and Lippman Jungers, the world’s leading legal search firm, today announced the addition of Josh Dull and Meredith Frank as partners.
  • Dull and Frank will focus on recruiting for New York firms while maintaining the national scope they’ve cultivated.
  • “I’ve had the pleasure of watching Josh and Meredith make some of the most impactful placements across the Southeast for years,” said Mark Jungers, Chief Strategy Officer of Johnson Downie and Lippman Jungers.
  • This recruitment follows the announcement of Johnson Downie and Lippman Junger’s strategic merger on March 7, which combined the firms of Johnson Downie and Lippman Jungers and the talents of Sabina Lippman, Clint Johnson and Mark Jungers.

Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults

Retrieved on: 
月曜日, 4月 29, 2024
Health, Infectious Diseases, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, MSD, Infection, FDA, Safety, 10A, Merck & Co., Epidemiology, Pediatrics, Abstract, Vaccine, PDUFA, Streptococcus, Patient, 9N, EMA, Medicine, 20A, Aes, Emory University, OPA, PCV20, Leucauge, European Medicines Agency, Food, MRK, Global health

The trial evaluated the immunogenicity, tolerability and safety of V116 compared to PPSV23 (pneumococcal vaccine, polyvalent [23-valent]) in adults 50 years of age and older who had not previously received a pneumococcal vaccine.

Key Points: 
  • The trial evaluated the immunogenicity, tolerability and safety of V116 compared to PPSV23 (pneumococcal vaccine, polyvalent [23-valent]) in adults 50 years of age and older who had not previously received a pneumococcal vaccine.
  • V116 is currently under review by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
  • The FDA granted V116 priority review with a Prescription Drug User Fee Act (PDUFA), or target action date, of June 17, 2024.
  • V116 is specifically designed to help protect adults from invasive pneumococcal disease; the serotypes in V116 account for approximately 83% of adult invasive pneumococcal disease in individuals 65 and older, according to U.S. Centers for Disease Control and Prevention data from 2018-2021.

Top Atlanta Facial Plastic and Reconstructive Surgeon, Dr. Benjamin Stong, is Selected as a Faculty Member at the 2024 Global Aesthetics Conference

Retrieved on: 
火曜日, 4月 30, 2024
Rhinoplasty, University, General surgery, Suite, Heart, Nose, Conference, Patient, Physician, Multimedia, Emory University, Lip, Knowledge, Scar, Dentistry

ATLANTA, April 30, 2024 /PRNewswire-PRWeb/ -- Dr. Benjamin Stong, a renowned Atlanta plastic and reconstructive surgeon, is proud to announce that he has been selected as a faculty member at the prestigious 2024 Global Aesthetics Conference. The conference, taking place from November 7th to 10th, 2024, will be held in the vibrant city of Miami, Florida. This conference brings together some of the brightest minds in the field, and Dr. Stong, widely known for his groundbreaking techniques, will be sharing his expertise and insights with an esteemed audience of physicians and industry partners from around the world.

Key Points: 
  • ATLANTA, April 30, 2024 /PRNewswire-PRWeb/ -- Dr. Benjamin Stong, a renowned Atlanta plastic and reconstructive surgeon , is proud to announce that he has been selected as a faculty member at the prestigious 2024 Global Aesthetics Conference.
  • The conference, taking place from November 7th to 10th, 2024, will be held in the vibrant city of Miami, Florida.
  • Dr. Stong's state-of-the-art facility, Kalos Facial Plastic Surgery, is located in Buckhead which is right in the heart of Atlanta, Georgia.
  • Kalos Facial Plastic Surgery is located at 371 East Paces Ferry Rd, Suite 850 in Atlanta, Georgia.